Alumis (ALMS) Shares Outstanding (2023 - 2025)
Alumis' (ALMS) quarterly Shares Outstanding (Entity) came in at $85.1 million in Q4 2025, up 197.75% year-on-year from $28.6 million in Q4 2024, and down 18.29% on a QoQ basis from $104.2 million in Q3 2025.
Alumis (ALMS) Shares Outstanding (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Shares Outstanding (Entity) data on file, last reported at $85.1 million in Q4 2025.
- On a quarterly basis, Shares Outstanding (Entity) rose 197.75% year-over-year to $85.1 million in Q4 2025; TTM through Dec 2025 was $85.1 million, a 197.75% increase from a year earlier, with the FY2025 full-year figure at $85.1 million, up 197.75% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $85.1 million, down from $104.2 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for ALMS reached as high as $104.2 million in Q3 2025 and fell as low as $23.8 million in Q4 2023.
- Historically, Shares Outstanding (Entity) has averaged $57.5 million across 3 years, with a median of $54.2 million in 2024.
- Across the five-year window, Shares Outstanding (Entity) increased 19.88% in 2024 and jumped 197.75% in 2025, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $23.8 million in 2023, then advanced by 19.88% to $28.6 million in 2024, then soared by 197.75% to $85.1 million in 2025.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $85.1 million in Q4 2025, $104.2 million in Q3 2025, and $76.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 62.06 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 198.10 Mn |
| 10 | Alumis | 2.37 Bn | 2.06 Bn | - | 85.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 85.10 Mn |
| Sep 30, 2025 | 104.15 Mn |
| Jun 30, 2025 | 76.56 Mn |
| Mar 31, 2025 | 54.41 Mn |
| Dec 31, 2024 | 28.58 Mn |
| Sep 30, 2024 | 53.97 Mn |
| Jun 30, 2024 | 2.70 Mn |
| Mar 31, 2024 | 33.05 Mn |
| Dec 31, 2023 | 23.84 Mn |
| Sep 30, 2023 | 2.65 Mn |
| Jun 30, 2023 | 2.64 Mn |